Showing results (141-150 of 259) with videos related to
Sort By:
Pageof 26
Cancer Research|July 1, 1992
Synergism between dipyridamole and cisplatin in human ovarian carcinoma cells in vitroA Jekunen, J Vick, R Sanga, et al.The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|October 17, 1998
Immunohistochemical analysis of the distribution of the human ATPase (hASNA-I) in normal tissues and its overexpression in breast adenomas and carcinomasB Kurdi-Haidar, D Heath, P Naredi, et al.Medical and Pediatric Oncology|January 1, 1984
Anaphylactic reaction to cytarabine: in vitro evidence that the response is immunoglobulin E mediatedM Markman, S B Howell, M King, et al.Pharmacological Reviews|December 21, 2000
Yeast mutants as a model system for identification of determinants of chemosensitivityP Perego, G S Jimenez, L Gatti, et al.British Journal of Cancer|February 1, 1994
Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitroA P Jekunen, R D Christen, D R Shalinsky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
The pharmacology of intraperitoneally administered bleomycinS B Howell, M Schiefer, P A Andrews, et al.Molecular Pharmacology|July 11, 1998
Sensitivity to cisplatin and platinum-containing compounds of Schizosaccharomyces pombe rad mutantsP Perego, F Zunino, N Carenini, et al.Cancer Treatment Reports|April 1, 1985
Modulation of the activity of PALA by dipyridamoleT C Chan, B Young, M E King, et al.Cancer Chemotherapy and Pharmacology|January 1, 1995
Synergistic interaction between cisplatin and tamoxifen delays the emergence of cisplatin resistance in head and neck cancer cell linesB Nakata, K D Albright, R M Barton, et al.The American Journal of Medicine|January 1, 1985
Infectious peritonitis in patients receiving intraperitoneal chemotherapyR A Kaplan, M Markman, W E Lucas, et al.Pageof 26